Research output per year
Research output per year
Personal profile
Personal profile
Dr. Zhong is an Assistant Professor of Rangel College of Pharmacy. Her research interest lies at the intersection of science, medicine and economics to assess clinical, economic and humanistic values of medical interventions and she conducts research on the costs and outcomes associated with pharmaceutical products.
She holds a Ph.D in Pharmacology and an M.A. in Economics from Duke University. She completed her post-doctoral fellowship training in Pharmacoeconomics and Outcomes research from University of California, San Francisco. She has conducted research in academic, international organization and industry settings.
Research interests
Dr. Zhong has conducted research using clinical trial data, real world data, large survey data and economic modeling to study cost-effectiveness of new interventions for cancer and neurological diseases. Since joining Texas A&M University as an assistant professor at the College of Pharmacy in 2015, she is conducting research in: evaluating utilization, costs and outcomes associated with medications and other health care services in patients with chronic diseases, health disparity, cost-effectiveness of new interventions, drug pricing and reimbursement.
External positions
Assistant Professor, Pharmaceutical Sciences, Texas A&M University
Jul 1 2015 → …
Fingerprint
Dive into the research topics where Lixian Zhong is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Dietary consumption trend and its correlation with global cancer burden: A quantitative and comprehensive analysis from 1990 to 2019
Luo, S., Lin, D., Lai, S., Lin, S., Zhong, L., Huang, X., Xu, X. & Weng, X., Jan 2024, In: Nutrition. 117, p. 112225 112225.Research output: Contribution to journal › Article › peer-review
-
Avelumab Maintenance Treatment After First-line Chemotherapy in Advanced Urothelial Carcinoma–A Cost-Effectiveness Analysis
Lin, D., Luo, S., Lin, S., Zhong, L., Zhou, W., Gu, D., Huang, X., Chen, Q., Xu, X. & Weng, X., Feb 2023, In: Clinical Genitourinary Cancer. 21, 1, p. 8-15 8 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Disease burden of prostate cancer from 2014 to 2019 in the United States: estimation from the Global Burden of Disease Study 2019 and Medical Expenditure Panel Survey
Lin, S., Lin, D., Li, Y., Zhong, L., Zhou, W., Wu, Y., Xie, C., Luo, S., Huang, X., Xu, X. & Weng, X., 2023, In: Epidemiology and health. 45, p. 1-8 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Effectiveness of the Program to Encourage Active, Rewarding Lives (PEARLS) to reduce depression: a multi-state evaluation
Smith, M. L., Steinman, L. E., Montoya, C. N., Thompson, M., Zhong, L. & Merianos, A. L., 2023, In: Frontiers in Public Health. 11, p. 1169257 1169257.Research output: Contribution to journal › Article › peer-review
Open Access -
External control arms: COVID-19 reveals the merits of using real world evidence in real-time for clinical and public health investigations
Silva, P., Janjan, N., Ramos, K., Udeani, G., Zhong, L., Ory, M. G. & Smith, M. L., 2023, In: Frontiers in Medicine. 10, p. 1198088 1198088.Research output: Contribution to journal › Review article › peer-review
Open Access